Simplex Trading
LRMR icon

Simplex Trading’s Larimar Therapeutics LRMR Stock Holding History

Simplex Trading’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Buy
46,200
+44,600
+2,788% +$178K ﹤0.01% 4252
2025
Q4 		$6.1K Sell
1,600
-34,600
-96% -$135K ﹤0.01% 7313
2025
Q3 		$116K Buy
36,200
+3,000
+9% +$11.2K ﹤0.01% 5574
2025
Q2 		$95K Buy
33,200
+18,500
+126% +$42.8K ﹤0.01% 5291
2025
Q1 		$31K Buy
14,700
+13,900
+1,738% +$43.9K ﹤0.01% 6220
2024
Q4 		$3K Sell
800
-7,600
-90% -$50.2K ﹤0.01% 7893
2024
Q3 		$55K Buy
8,400
+2,000
+31% +$16.1K ﹤0.01% 5805
2024
Q2 		$46K Sell
6,400
-26,600
-81% -$204K ﹤0.01% 6174
2024
Q1 		$250K Buy
+33,000
New +$257K ﹤0.01% 4608
2020
Q3 		– Sell
-3
Closed -$3K – 8164
2020
Q2 		$3K Buy
+3
New +$35 ﹤0.01% 7157
2019
Q3 		– Sell
-6
Closed -$8K – 7602
2019
Q2 		$8K Buy
6
+2
+50% +$53 ﹤0.01% 6226
2019
Q1 		$13K Sell
4
-2
-33% -$103 ﹤0.01% 5996
2018
Q4 		$34K Buy
+6
New +$592 ﹤0.01% 4902
2018
Q3 		– Hold
0
– -$1K – 7760
2018
Q2 		– Sell
-1
Closed -$85 – 7163
2018
Q1 		$2K Buy
+1
New +$85 ﹤0.01% 5296
2017
Q3 		– Sell
-5
Closed -$8K – 6290
2017
Q2 		$8K Buy
+5
New +$256 ﹤0.01% 4175
2017
Q1 		– Sell
-33
Closed -$1K – 6489
2016
Q4 		$1K Sell
33
-2
-6% -$81 ﹤0.01% 5428
2016
Q3 		$15K Buy
35
+34
+3,400% +$1.54K ﹤0.01% 3254
2016
Q2 		$1K Sell
1
-5
-83% -$395 ﹤0.01% 5334
2016
Q1 		$6K Sell
6
-2
-25% -$158 ﹤0.01% 3933
2015
Q4 		$16K Sell
8
-7
-47% -$1.12K ﹤0.01% 2887
2015
Q3 		$282K Buy
+15
New +$6.76K 0.02% 725

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Simplex Trading's LRMR Position: Q1 2026 in Review

Simplex Trading sold out of Larimar Therapeutics (LRMR) in Q1 2026, closing a stake of 30,522 shares — an estimated $122K sold.

Simplex Trading first reported a position in LRMR in Q2 2015 and held it in 27 quarters. The position peaked at $695K in Q3 2025. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Simplex Trading reported no remaining Larimar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 30,522 Larimar Therapeutics shares in Q1 2026, an estimated $122K.
  • Simplex Trading first reported a position in Larimar Therapeutics in Q2 2015 and held it in 27 quarters.
  • Simplex Trading's Larimar Therapeutics position peaked at $695K in Q3 2025.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.